wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33416342-4046A6E0-8A35-4EC5-B94F-800A92D25D1E
Q33416342-4046A6E0-8A35-4EC5-B94F-800A92D25D1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416342-4046A6E0-8A35-4EC5-B94F-800A92D25D1E
Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours.
P2860
Q33416342-4046A6E0-8A35-4EC5-B94F-800A92D25D1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33416342-4046A6E0-8A35-4EC5-B94F-800A92D25D1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
04793ef08cf7cee6a9fa8481b37557edb93d6125
P2860
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.